 |
Amantadine HCl |
|---|---|
| Trade Name | |
| Orphan Indication | Levodopa-induced dyskinesia |
| USA Market Approval | USA |
| USA Designation Date | 2015-07-20 00:00:00 |
| Sponsor | Osmotica Pharmaceutical Corporation;Regulatory, Clinical Operations & Legal, Lumina Station #2, Suite 209-A;Wilmington, North Carolina, 28403 |
